Vitamin D

Doctors have known that low levels of vitamin D are linked to certain kinds of cancers as well as to diabetes and asthma, but new research also shows that the vitamin can kill human cancer cells.

Evidence suggest that vitamin D (Vitamin D3) may be protective against some cancers. Clinical studies now show vitamin D deficiency to be associated with four of the most common cancers: Breast, Prostate, Colon, and Skin cancer.

It is well established that Vitamin D (Vitamin D3) acts as an effective regulator of cell growth and differentiation in a number of different cell types, including cancer cells. Through this action, Vitamin D behaves as a protective factor, which decreases the risk of getting cancer.

Vitamin D may also go beyond cancer prevention and provide tumor therapy. Much ado has been made of pharmaceutical angiogenesis inhibitors agents that help inhibit the growth of new, undesirable blood vessels that tumors require for nutrient supply and growth. Laboratory tests have shown vitamin D to be a potent angiogenesis inhibitor.

Vitamin D also works at another stage of cancer development. Tumor cells are young, immortal cells that never grow up, mature and die off. Because vitamin D derivatives have been shown to promote normal cell growth and maturation.


Vitamin D and the Immune system

T cells are dormant immune cells until they are activated to detect and kill bacteria and viruses. Without vitamin D in the blood, activation would not take place. People with vitamin D deficiency might be more susceptible to infection or that vitamin D supplements might boost immunity.

Studies have found that ‘naive’ T cells that had not been primed produced only a small amount of phospholipase C-γ1. However, following priming by exposure to the activator immune system molecules, the T cells began to produce far more phospholipase C-γ1. For this to occur, the T cells needed to be in the presence of vitamin D and the vitamin D receptor. 

To learn more about how Vitamin D can help you to fight cancer, contact us today.